Piloting international production of rapid relative effectiveness assessments of pharmaceuticals

International Journal of Technology Assessment in Health Care

Volumn 30, Issue 5, 2015, Pages 521-529

  Kleijnen, Sarah ^a,k   Pasternack, Iris ^a,b   Rannanheimo, Piia ^c   Vuola, Jenni M ^d   Van De Casteele, Marc ^e,l   Bucsics, Anna ^f,m   Pulis, Isabelle Zahra ^g   Di Bidino, Rossella ^h   Sacchini, Dario ⁱ   Montilla, Simona ^j   Abrishami, Payam ^a   Sammut, Sylvana Magrin ^g   Muscolo, Luisa Anna Adele ^j   Happonen, Pertti ^c   Goettsch, Wim G ^a,k  

^a Zorginstituut Nederland   (Netherlands)

^b Summaryx Ltd   (Finland)

^c Information Services and Development Division   (Finland)

^d GLAXOSMITHKLINE   (Finland)

^e Directie Farmaceutisch Beleid   (Belgium)

^f Department of Pharmaceutical Affairs ^*  (Austria)

^g ST LUKE S HOSPITAL   (Malta)

^h FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

ⁱ CATHOLIC UNIVERSITY   (Italy)

^j ITALIAN MEDICINES AGENCY   (Italy)

^k UTRECHT UNIVERSITY   (Netherlands)

^l UNIVERSITY OF LEUVEN   (Belgium)

^m UNIVERSITY OF VIENNA   (Austria)

more..

Author keywords

Comparative effectiveness research; International cooperation; Pilot projects; Technology assessment

Indexed keywords

INTERNATIONAL COOPERATION;

COMPARATIVE EFFECTIVENESS RESEARCHES; DIFFERENT DOMAINS; EFFECTIVENESS ASSESSMENT; EUROPEAN COUNTRIES; HEALTH TECHNOLOGY ASSESSMENTS; PILOT PROJECTS; RENAL CELL CARCINOMA; TECHNOLOGY ASSESSMENTS;

TECHNOLOGY TRANSFER;

PAZOPANIB; ANGIOGENESIS INHIBITOR; PYRIMIDINE DERIVATIVE; SULFONAMIDE;

ADVANCED CANCER; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; COMPARATIVE EFFECTIVENESS; COMPUTER PROGRAM; DECISION MAKING; EUROPEAN; FEEDBACK SYSTEM; HEALTH SURVEY; HTA CORE MODEL; HUMAN; INTERNATIONAL COOPERATION; KIDNEY METASTASIS; MAJOR CLINICAL STUDY; ORGANIZATION; PILOT STUDY; PRACTICE GUIDELINE; RELATIVE EFFECTIVENESS ASSESSMENT; WORKLOAD; CARCINOMA, RENAL CELL; EUROPE; KIDNEY NEOPLASMS; ORGANIZATION AND MANAGEMENT; PROGRAM EVALUATION; QUESTIONNAIRE;

ANGIOGENESIS INHIBITORS; CARCINOMA, RENAL CELL; COMPARATIVE EFFECTIVENESS RESEARCH; EUROPE; HUMANS; INTERNATIONAL COOPERATION; KIDNEY NEOPLASMS; PILOT PROJECTS; PROGRAM EVALUATION; PYRIMIDINES; QUESTIONNAIRES; SULFONAMIDES; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84924352444     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462314000622     Document Type: Article

References (10)

1. Kleijnen S, Goettsch W, d'Andon A, et al. EUnetHTA JA WP5: Relative Effectiveness Assessment (REA) of Pharmaceuticals. Background review. July 2011. http://eunethta.fedimbo.belgium.be/sites/5026.fedimbo.belgium.be/files/Final%20version%20of%20 Background%20Review%20on%20Relative%20Effectiveness% 20Assessment%2Bappendix.pdf (accessed September 19, 2013).
2. Hutton J, Trueman P, Facey K. Harmonization of evidence requirements for health technology assessment in reimbursement decision making. Int J Technol Assess Health Care. 2008;24:511-517.
3. High Level Pharmaceutical Forum 2005-2008. Conclusions and recommendations. 2008 http://ec.europa.eu/enterprise/sectors/healthcare/files/docs/pharmaforum-final-conclusions-brochure-en.pdf (accessed September 19, 2013).
4. Kleijnen S, George E, Goulden S, et al. Relative effectiveness assessment of pharmaceuticals: Similarities and differences in 29 jurisdictions. Value Health. 2012;15(6):954-960.
5. Council Directive 89/105/EEC of 21 December 1988 relating to the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of national health insurance systems. Official Journal L 040, 11/02/1989 P. 0008-0011.
6. Lampe K, Mäkelä M, Garrido MV, et al. The HTA core model: A novel method for producing and reporting health technology assessments. Int J Technol Assess Health Care. 2009;25(Suppl 2):9-20.
7. EUnetHTA Joint Action 1 WP5. Pazopanib for the treatment of advanced renal cell carcinoma Pilot assessment using the draft HTA Core Model for Rapid Relative Effectiveness Assessment model. December 2012 http://eunethta.fedimbo.belgium.be/sites/5026.fedimbo.belgium.be/files/Final%20version%20of% 20Background%20Review%20on%20Relative%20Effectiveness% 20Assessment%2Bappendix.pdf (accessed September 19, 2013).
8. Pasternack I, Anttila H, Mäkelä M, et al. Testing the HTA core model: Experiences from two pilot projects. Int J Technol Assess Health Care. 2009;25(Suppl 2):21-27.
9. EUnetHTA Joint Action 2 WP8. HTA Core Model® Online Handbook. Version 1.4. 17 Sep 2012 http://meka.thl.fi/htacore/ViewHandbook. aspx (accessed February 10, 2014).
10. High Level Pharmaceutical Forum. Core principles on relative effectiveness. 2008 http://ec.europa.eu/enterprise/sectors/healthcare/files/docs/rea-principles-en.pdf (accessed September 19, 2013).